Innovation Medical Management Co., Ltd. Class A

Innovation Medical Management Co., Ltd. Class A

SSZSE:002173
16.23
CNY
-0.01
(-0.06%)
-0.21EPS
7.23BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1.51
0.85
0.67
1.73
1.99
2.5
1.92
1.59
1.58
1.55
1.88
1.82
1.79
1.68
Basic EPS, GAAP
0.12
-0.05
-0.32
0.26
0.31
0.07
-2.53
-0.69
-0.23
-0.16
-0.08
-0.21
-0.08
-0.21
Free Cash Flow per Basic Share
-0.12
-0.03
0.15
0.16
0.09
-0.64
-0.14
0.05
-0.15
-0.32
-0.2
-0.12
-0.02
- -
Dividend per Share
0.14
0.15
0.13
0.05
0.03
0.15
0.03
0.01
0.01
- -
- -
0.01
0.01
0.01
Book Value per Share
2.45
2.33
2.04
7.73
8.02
7.96
5.43
4.71
4.36
4.2
4.16
4.03
3.97
3.74
Tangible Book Value per Share
2.2
2.13
1.88
5.21
5.5
5.45
4.86
4.43
4.08
3.93
3.87
3.73
3.55
3.33
Basic Weighted Avg Shares
198
217
204
441
454
424
455
456
450
459
429
447
436
435
Sales/Revenue/Turnover
299
183
137
763
905
1,059
872
724
712
710
806
816
781
730
Operating Margin (%)
21.41
6.14
-28.97
24.88
26.67
23.49
-9.35
-14.02
-10.91
-12.95
-4.25
-7.47
-8.92
-13.41
Depreciation Expense
8
8
9
83
93
95
104
112
116
110
107
102
96
- -
Net Income, GAAP
24
-11
-65
115
141
30
-1,150
-315
-103
-73
-34
-94
-35
-90
Effective Tax Rate (%)
20.43
- -
- -
28.22
32.94
69.25
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
7.93
-5.91
-47.68
15.04
15.55
2.8
-131.85
-43.42
-14.54
-10.35
-4.26
-11.51
-4.46
-12.31
Working Capital
333
322
266
1,514
1,484
1,254
912
743
594
449
408
278
248
259
LT Debt
- -
5
5
85
42
67
39
54
34
22
20
23
25
11
Total Equity
502
479
413
3,532
3,656
3,620
2,470
2,144
1,979
1,905
1,871
1,777
1,764
1,662
Return on Invested Capital (%)
2.12
- -
- -
4.96
4
0.95
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
4.78
- -
- -
6.18
4.02
1.02
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
4.84
-2.21
-14.65
5.82
3.92
0.82
-37.78
-13.64
-5.02
-3.78
-1.82
-5.15
-1.98
-5.26

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
57
62
100
LT Borrowings
8
8
- -
LT Finance Leases
17
16
11
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
441
441
441
Market Capitalization
9,492
10,997
7,228

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
544
519
564
Cash, Cash Equivalents & STI
412
405
463
Accounts Receivable, Net
90
76
63
Inventories
36
32
32
Total Current Liabilities
296
281
304
Payables & Accruals
- -
- -
- -
ST Debt
57
62
100
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
69.3%
-3.79%
-0.71%
Free Cash Flow
-130.38%
-86.5%
-84.18%
Net Income, GAAP
-441.78%
-7.66%
-62.9%
Sales/Revenue/Turnover
46.62%
1.71%
-4.26%
Total Cash Common Dividend
19.51%
11.63%
-0.02%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
201
207
202
206
816
2025
193
208
- -
184
781
2026
167
171
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.01
-0.03
-0.03
-0.15
-0.21
2025
-0.03
0.01
- -
-0.09
-0.08
2026
-0.06
-0.06
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.01
2025
- -
- -
- -
- -
0.01
2026
- -
- -
- -
- -
- -

Company Description

CEO
Jianjian Ma
Full Time Employees
2,572
Sector
Distribution services
Industry
Wholesale distributors
Address
Zhengjiahu Village Zhuji ZH China 311804
IPO Date
Sep 26, 2007
Website
chxyl.com
Business
Innovation Medical Management Co., Ltd. engages primarily in the medical services industry in China, operating multiple hospitals including Jianhua Hospital, Kanghua Hospital, Futian Hospital, and Mingzhu Hospital. The company provides a comprehensive range of medical services including outpatient, inpatient, and medical examinations. Additionally, it offers research, development, and technical consulting services focused on medical devices and pharmaceutical products. Founded in 1997 and headquartered in Zhuji, China, the company also participates in hospital management consulting and industrial investment in the healthcare sector. Recent major developments include the company completing an equity buyback worth CNY 100 million in early 2025, demonstrating financial consolidation efforts. The company continues to expand and refine its medical services portfolio across its operating hospitals, emphasizing high-quality healthcare service delivery. Innovation Medical Management Co., Ltd. remains focused on strengthening its medical research and development capabilities and technical consulting, positioning itself to advance within China’s evolving healthcare market. The company was formerly known as Qianzu Pearl Group Co., Ltd. before its name change to the current title in June 2016. Its operations are focused primarily in China, targeting both general and specialized healthcare markets through its owned hospitals and service offerings. The firm’s strategic focus remains on enhancing its hospital management and medical services infrastructure along with research and consultancy in medical products, supporting its comprehensive healthcare service ecosystem.